EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
58 hedge funds and large institutions have $94.3M invested in Eidos Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
46% less capital invested
Capital invested by funds: $174M → $94.3M (-$79.7M)
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.75M | |
| 2 | +$5.77M | |
| 3 | +$2.79M | |
| 4 |
AIG
American International Group
New York
|
+$2.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.48M |
Top Sellers
| 1 | -$6.51M | |
| 2 | -$5.71M | |
| 3 | -$4.31M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$3.29M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.54M |